Intermediate Markers in Cancer Research: Theoretical and Practical Issues in the Use of Surrogate Endpoints

This publication has 27 references indexed in Scilit:

• Modulation of Abnormal Colonic Epithelial Cell Proliferation and Differentiation by Low-Fat Dairy Foods
  JAMA, 1998
• Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in linxian, china
  Cancer, 1998
• Design of the Women’s Health Initiative Clinical Trial and Observational Study
  Controlled Clinical Trials, 1998
• Alterations in DNA methylation may play a variety of roles in carcinogenesis
  Cell, 1995
• Modeling the Relationship of Survival to Longitudinal Data Measured with Error. Applications to Survival and CD4 Counts in Patients with AIDS
  Journal of the American Statistical Association, 1995
• Screening for ovarian cancer: What are the optimal surrogate endpoints for clinical trials?
  Journal of Cellular Biochemistry, 1995
• Recent Progress in Defining the Epidemiology of Human Papillomavirus Infection and Cervical Neoplasia
  JNCI Journal of the National Cancer Institute, 1992
• Surrogate endpoints in clinical trials: Definition and operational criteria
  Statistics in Medicine, 1989
• MAMMOGRAPHIC PARENCHYMAL PATTERNS AS INDICATORS OF BREAST CANCER RISK
  American Journal of Epidemiology, 1989
• Retroviruses
  Published by Springer Nature ,1989